Literature DB >> 17333824

Occurrence of enteropathogenic bacteria in children under 5 years with diarrhoea in south Tehran.

M M S Dallal1, M R Khorramizadeh, K MoezArdalan.   

Abstract

This study was carried out on 1600 rectal swabs from children under 5 years of age admitted at the health centre in Islamshahr, Tehran province, Islamic Republic of Iran, during 1998-99. The specimens were examined for various bacterial pathogens. Isolation rates were: enteropathogenic Escherichia coli 6.8%, Shigella spp. 3.4%, Salmonella spp. 2.9%, Campylobacter spp. 0.9%, Yersinia spp. 0.7%. The isolation rate was highest in the summer, except for Yersinia spp., which was predominantly isolated in spring. The results of this study demonstrate the significance of Yersinia spp. and Campylobacter spp. in patients with diarrhoea.

Entities:  

Mesh:

Year:  2006        PMID: 17333824

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

1.  Characterization of Antimicrobial Susceptibility, Extended-Spectrum β-Lactamase Genes and Phylogenetic Groups of Enteropathogenic Escherichia coli Isolated from Patients with Diarrhea.

Authors:  Erfaneh Jafari; Saeid Mostaan; Saeid Bouzari
Journal:  Osong Public Health Res Perspect       Date:  2020-10

2.  Prevalence of multi drug resistant enteropathogenic and enteroinvasive Escherichia coli isolated from children with and without diarrhea in Northeast Indian population.

Authors:  Karuppasamy Chellapandi; Tapan Kumar Dutta; Indu Sharma; Surajit De Mandal; Nachimuthu Senthil Kumar; Lalsanglura Ralte
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-07-11       Impact factor: 3.944

3.  Frequency of five Escherichia Coli pathotypes in Iranian adults and children with acute diarrhea.

Authors:  Sana Eybpoosh; Saeid Mostaan; Mohammad Mehdi Gouya; Hossein Masoumi-Asl; Parviz Owlia; Babak Eshrati; Mohammad Reza Montazer Razavi Khorasan; Saeid Bouzari
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.